Literature DB >> 31586244

Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.

Ziwei Zeng1,2,3, Shuangling Luo1,2,3, Junji Chen1,2,3, Yonghua Cai1,2,3, Xingwei Zhang1,2,3, Liang Kang4,5,6.   

Abstract

INTRODUCTION: Total mesorectal excision (TME) is the standard procedure for middle lower rectal cancer, and transanal total mesorectal excision (taTME) was founded as a valid alternative to the open and laparoscopic TME. The quality of the procedure performed is important for prognosis of patients. This study was designed to compare the pathological results of taTME with those of laparoscopic TME (laTME), based on the data from a randomized control trial (RCT: NCT02966483).
METHODS: Between April 2016 and November 2018, all rectal cancer patients who underwent taTME or laTME in the Sixth Affiliated Hospital of Sun Yat-sen University (Guangzhou, China) and enrolled in the RCT were included in this study. The data from all participants were prospectively input in a standardized database.
RESULTS: In total 128 patients were included in the taTME group and 133 patients were included in the laTME group. The demographics and tumor characteristics were not significantly different between the two group. T3 or N0 lesions were most common in both groups. The mesorectum specimen was complete or nearly complete in all patients. The positive distal resection margin (DRM) was detected in 2 (1.5%) cases in the laTME group versus no cases in the taTME group (P = 0.498), and the distance between the tumor and DRM in the taTME group (1.4 ± 1.1) may have the longer tendency than that in the laTME group (1.3 ± 0.9) (P = 0.745). The positive circumferential resection margin was detected in 2 cases in each group (P = 0.674). The median number of resected lymph nodes was 15.0 in taTME group versus 16.0 in the laTME group (P = 0.069).
CONCLUSION: The pathological outcomes between transanal and laparoscopic total mesorectal excision are similar. The rate of positive resection margin could not be significant decreased, nonetheless the decrease trend could be shown.

Entities:  

Keywords:  Circumferential resection margin; Distal resection margin; Mesorectal resection quality; Rectal cancer; Total mesorectal excision; Transanal total mesorectal excision

Mesh:

Year:  2019        PMID: 31586244     DOI: 10.1007/s00464-019-07167-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  8 in total

1.  Transanal total mesorectal excision combined with intersphincteric resection has similar long-term oncological outcomes to laparoscopic abdominoperineal resection in low rectal cancer: a propensity score-matched cohort study.

Authors:  Zhi-Hang Liu; Zi-Wei Zeng; Hai-Qing Jie; Liang Huang; Shuang-Ling Luo; Wen-Feng Liang; Xing-Wei Zhang; Liang Kang
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-06-14

2.  taTME: boom or bust?

Authors:  Liang Kang; Patricia Sylla; Sam Atallah; Massaki Ito; Steven D Wexner; Jian-Ping Wang
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-02-21

3.  Transanal versus Laparoscopic Total Mesorectal Excision in Male Patients with Low Tumor Location after Neoadjuvant Therapy: A Propensity Score-Matched Cohort Study.

Authors:  Ze Li; Jingkun Xiao; Yujie Hou; Xingwei Zhang; Haiqing Jie; Huashan Liu; Lei Ruan; Ziwei Zeng; Liang Kang
Journal:  Gastroenterol Res Pract       Date:  2022-02-27       Impact factor: 2.260

4.  UEG and EAES rapid guideline: Systematic review, meta-analysis, GRADE assessment and evidence-informed European recommendations on TaTME for rectal cancer.

Authors:  Marco Milone; Michel Adamina; Alberto Arezzo; Nona Bejinariu; Luigi Boni; Nicole Bouvy; F Borja de Lacy; Raphaëla Dresen; Konstantinos Ferentinos; Nader K Francis; Joe Mahaffey; Marta Penna; George Theodoropoulos; Katerina Maria Kontouli; Dimitris Mavridis; Per Olav Vandvik; Stavros A Antoniou
Journal:  Surg Endosc       Date:  2022-02-25       Impact factor: 4.584

5.  Structured training curriculums for transanal total mesorectal excision in China: refinement is needed.

Authors:  Ximo Xu; Zhenghao Cai; Hong Zhang; Qing Xu; Mingyang Ren; Abe Fingerhut; Dachong Sha; Minhua Zheng; Jianwen Li; Yang Deng; Xiao Yang; Sen Zhang; Batuer Aikemu; Wei Qin; Duohuo Shu; Xinxiang Li; Jun You; Quan Wang; Bo Feng
Journal:  Ann Transl Med       Date:  2022-04

6.  Transanal total mesorectal excision after incomplete endoscopic submucosal dissection for early-stage low rectal cancer: A small case series.

Authors:  Mamoru Miyasaka; Shuji Kitashiro; Shunichi Okushiba; Tetsuya Sumiyoshi; Hiroko Takeda; Satoshi Hirano
Journal:  Int J Surg Case Rep       Date:  2022-09-02

7.  Clinical Robotic Surgery Association (India Chapter) and Indian rectal cancer expert group's practical consensus statements for surgical management of localized and locally advanced rectal cancer.

Authors:  S P Somashekhar; Avanish Saklani; Jagannath Dixit; Jagdish Kothari; Sandeep Nayak; O V Sudheer; Surender Dabas; Jagadishwar Goud; Venkatesh Munikrishnan; Pavan Sugoor; Prasanth Penumadu; C Ramachandra; Shilpa Mehendale; Akhil Dahiya
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

Review 8.  Clinical Status and Future Prospects of Transanal Total Mesorectal Excision.

Authors:  Zichao Guo; Xiaopin Ji; Shaodong Wang; Yaqi Zhang; Kun Liu; Changgang Wang; Yang Deng; Tao Zhang; Xi Cheng; Ren Zhao
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.